Thalidomide as a targeted therapy for multiple myeloma.
Dan
Kazuo
K
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy*; D006435:Renal Dialysis; D013792:Thalidomide / Q000627:therapeutic use*
D020533:Angiogenesis Inhibitors; D007166:Immunosuppressive Agents; D013792:Thalidomide